Division of Pediatric Hematology and Oncology

Since 2007, Hyundai Hope on Wheels, which includes funding from Hyundai Motor America and local dealerships, has awarded more than $2 million in funding to pediatric cancer researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

Vanderbilt's Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).

Multi-institutional study finds that enrollment and outcomes were similar across various groups of children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center

Cancer at the age of 13 forced him to give up his dream of professional football. While undergoing treatment, he found a new dream.

Debra Friedman, MD, MS, has been awarded a $100,000 Hyundai Hope On Wheels Impact Award to examine outcomes in pediatric, adolescent and young adult sarcoma patients and survivors.